SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 368 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,246,000 | +49.2% | 26,483 | -8.9% | 0.36% | +22.3% |
| Q1 2020 | $2,845,000 | -32.9% | 29,080 | -11.5% | 0.29% | -6.4% |
| Q4 2019 | $4,240,000 | +56.9% | 32,855 | -8.4% | 0.31% | +53.2% |
| Q3 2019 | $2,703,000 | -55.2% | 35,882 | -9.5% | 0.20% | -51.3% |
| Q2 2019 | $6,028,000 | +21.4% | 39,668 | -4.8% | 0.42% | +32.0% |
| Q1 2019 | $4,964,000 | -0.8% | 41,649 | -9.2% | 0.32% | -12.2% |
| Q4 2018 | $5,004,000 | -36.1% | 45,852 | -5.4% | 0.36% | -16.7% |
| Q3 2018 | $7,825,000 | -52.9% | 48,449 | -61.5% | 0.43% | -54.1% |
| Q2 2018 | $16,616,000 | +70.8% | 125,707 | -4.3% | 0.94% | +74.4% |
| Q1 2018 | $9,731,000 | -4.5% | 131,334 | -28.3% | 0.54% | +11.1% |
| Q4 2017 | $10,187,000 | -12.6% | 183,091 | -28.8% | 0.49% | +2.5% |
| Q3 2017 | $11,656,000 | – | 256,970 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |